> All the big AIM fraud exposés
> 300 articles and podcasts a month
> Hot share tips
> Original investigations by our experienced team
> No ads, no click-bait, no auto-play videos
By ShareProphets | Thursday 13 September 2018
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
The great success that was the 2018 UK Investor Show saw six 'Dragon's Den' sessions where a number of CEOs each gave a 1 minute (well, supposed to be!) pitch and three 'Dragons' at each session each picked a stock for a £1,000 investment. With the show having been in April, here’s a further monthly performance update...
Despite having slid back somewhat recently, OptiBiotix Health (OPTI) sees Tom continue to lead. He and Nigel Wray also continue to benefit from FairFX (FFX), whilst Steve Moore has been boosted by an improved Europa Metals (EUZ). Meanwhile, though continuing to struggle to follow the success of his 2017 selection (Versarien @22.4p), at least Plutus PowerGen (PPG) moves off the bottom for the Pizza Hardman, Darren Atwater...
|Code||Company||Price paid (p)||bid' price now (p)||Performance||Dragon|
|OPTI||OptiBiotix Health||57.75||90||56%||Tom Winnifrith|
|EUZ||Europa Metals||0.0797||0.105||32%||Steve Moore|
|FFX||FairFX||105||131||25%||TW, Nigel Wray|
|BZT||Bezant Resources||0.4427||0.375||-15%||Gary Newman|
|PPG||Plutus PowerGen||1.699||1||-41%||Darren Atwater|
|BST||Big Sofa Technologies||13.75||8||-42%||TW, SM, Brian Kinane|
|PHE||PowerHouse Energy||0.55||0.3||-45%||NW, GN|
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments are turned off for this article.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen